Sands Capital Ventures »

Spyglass Pharma shares owned by Sands Capital Ventures

Quarter-by-quarter ownership of Spyglass Pharma shares owned by Sands Capital Ventures from 13F filings

Historical chart of Sands Capital Ventures investment in Spyglass Pharma

Tip: Access up to 7 years of quarterly data

All positions including Spyglass Pharma held by Sands Capital Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spyglass Pharma by Sands Capital Ventures

Quarter filed Position value Share count Share price at filing
2026-03-31 $65M 2.5M 25.91

More positions owned by Sands Capital Ventures

Nu Hldgs Ord Shs Cl A (NU)
Klaviyo Com Ser A (KVYO)
Spyglass Pharma Com Shs
Beta Bionics (BBNX)
Inhibikase Therapeutics Com New (IKT)
Coupang Cl A (CPNG)
Samsara Com Cl A (IOT)
Doordash Cl A (DASH)
Bioage Labs (BIOA)
10x Genomics Cl A Com (TXG)
Datadog Cl A Com (DDOG)
Acumen Pharmaceuticals (ABOS)
Toast Cl A (TOST)
Tarsus Pharmaceuticals (TARS)
Servicetitan Shs Cl A (TTAN)

View all positions for Sands Capital Ventures

Top funds holding Spyglass Pharma

RA Capital Management
NEA Management Company
Sands Capital Ventures
Samsara BioCapital
Vestal Point Capital
Deerfield Management Company
Millennium Management
Vanguard Capital Management
First Light Asset Management
Franklin Resources
Standard Life Aberdeen
BlackRock
Geode Capital Management
Monashee Investment Management
Vanguard Fiduciary Trust

View all funds holding Spyglass Pharma